Indivior Pharmaceuticals, Inc. (INDV)

CIK 1625297 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Indivior Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 2026424B30001104659-26-107070
Sep 9, 2026S-4/A0001104659-26-106390
Aug 28, 2026S-40001104659-26-103278
Aug 27, 202640002014440-26-000012
Aug 13, 2026SCHEDULE 13D/A0001140361-26-032874
Aug 5, 202640002014440-26-000010
Aug 4, 20264250001193125-26-331036
Aug 3, 20268-K0001193125-26-329618
Aug 3, 20268-K0001193125-26-329520
Aug 3, 202610-Q0001628280-26-051895
Aug 3, 20264250001193125-26-329517
Aug 3, 20268-K0001193125-26-329513
Aug 3, 20264250001193125-26-329620
Aug 3, 20264250001193125-26-329521
Aug 3, 20264250001193125-26-330875
Jul 13, 202640002014639-26-000011
Jul 10, 20261440001959173-26-005188
Jun 23, 202640001443841-26-000007
Jun 12, 202640002014639-26-000009
Jun 11, 20261440001959173-26-004549
Jun 10, 202640002014866-26-000011
Jun 8, 20261440001959173-26-004422
Jun 8, 2026144/A0001959173-26-004434
May 15, 20268-K0001625297-26-000024
May 15, 2026SCHEDULE 13G/A0001013594-26-000584